RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

Diğer sürümleri göster (1)

Aim. To evaluate risk of repeated atherothrombotic events in patients survived acute coronary syndrome (ACS) and having poorly reduced platelet aggregation (proven by optical aggregometry) in response to acetylsalicylic acid (ASA) therapy.Material and methods. 200 patients with ACS (aged 56,6±9,2 y....

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Столичная издательская компания 2016-01-01
Seri Bilgileri:Рациональная фармакотерапия в кардиологии
Konular:
acute coronary syndrome
antiaggregants
therapy efficacy
cardiovascular сomplications
Online Erişim:https://www.rpcardio.online/jour/article/view/734

Internet

https://www.rpcardio.online/jour/article/view/734

Benzer Materyaller